Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide

Tsi S. Huang, S. S J Lee, Hui Z. Tu, Wen Kuei Huang, Yao Shen Chen, Chung K. Huang, Shue R. Wann, Hsi Hsun Lin, Yung Ching Liu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: Tentative standards for testing MICs for Mycobacterium tuberculosis include agar dilution and the BACTEC method. However, the conventional agar dilution method requires 3-5 weeks to complete; whereas BACTEC, although a rapid test, involves the use of radioisotopes. In contrast, the MGIT 960 system uses a fluorescence quenching based oxygen sensor that can be read automatically. This system is not only robust, safe and simple, but has been validated for susceptibility tests of first-line antituberculous agents. Methods: We evaluated 46 clinical strains of M. tuberculosis isolated from patients admitted to Kaohsiung Veterans General Hospital. Testing of MICs of ciprofloxacin and ethionamide was carried out by MGIT 960 and compared with the agar dilution method. Results: Good agreement was found between MGIT 960 and agar dilution. The greatest concordance between the agar dilution and MGIT assay at ±1 and ±2 dilution was 80.4% and 97.8% for ciprofloxacin, and 82.6% and 93.5% for ethionamide, respectively. Conclusion: MGIT 960 was found to be comparable to the current NCCLS standard method, agar dilution, and has the advantage of being rapid (obtaining results within 5-17 days, average 8.9 days) and easy to achieve standardization.

Original languageEnglish
Pages (from-to)600-603
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume53
Issue number4
DOIs
Publication statusPublished - Apr 2004
Externally publishedYes

Fingerprint

Ethionamide
Ciprofloxacin
Mycobacterium tuberculosis
Agar
Veterans Hospitals
Radioisotopes
General Hospitals
Fluorescence
Oxygen

Keywords

  • M. tuberculosis
  • Minimum inhibitory concentration
  • Susceptibility testing

ASJC Scopus subject areas

  • Microbiology
  • Pharmacology

Cite this

Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide. / Huang, Tsi S.; Lee, S. S J; Tu, Hui Z.; Huang, Wen Kuei; Chen, Yao Shen; Huang, Chung K.; Wann, Shue R.; Lin, Hsi Hsun; Liu, Yung Ching.

In: Journal of Antimicrobial Chemotherapy, Vol. 53, No. 4, 04.2004, p. 600-603.

Research output: Contribution to journalArticle

Huang, Tsi S. ; Lee, S. S J ; Tu, Hui Z. ; Huang, Wen Kuei ; Chen, Yao Shen ; Huang, Chung K. ; Wann, Shue R. ; Lin, Hsi Hsun ; Liu, Yung Ching. / Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide. In: Journal of Antimicrobial Chemotherapy. 2004 ; Vol. 53, No. 4. pp. 600-603.
@article{e17da12cffb04309b93c5defa1b0327b,
title = "Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide",
abstract = "Objectives: Tentative standards for testing MICs for Mycobacterium tuberculosis include agar dilution and the BACTEC method. However, the conventional agar dilution method requires 3-5 weeks to complete; whereas BACTEC, although a rapid test, involves the use of radioisotopes. In contrast, the MGIT 960 system uses a fluorescence quenching based oxygen sensor that can be read automatically. This system is not only robust, safe and simple, but has been validated for susceptibility tests of first-line antituberculous agents. Methods: We evaluated 46 clinical strains of M. tuberculosis isolated from patients admitted to Kaohsiung Veterans General Hospital. Testing of MICs of ciprofloxacin and ethionamide was carried out by MGIT 960 and compared with the agar dilution method. Results: Good agreement was found between MGIT 960 and agar dilution. The greatest concordance between the agar dilution and MGIT assay at ±1 and ±2 dilution was 80.4{\%} and 97.8{\%} for ciprofloxacin, and 82.6{\%} and 93.5{\%} for ethionamide, respectively. Conclusion: MGIT 960 was found to be comparable to the current NCCLS standard method, agar dilution, and has the advantage of being rapid (obtaining results within 5-17 days, average 8.9 days) and easy to achieve standardization.",
keywords = "M. tuberculosis, Minimum inhibitory concentration, Susceptibility testing",
author = "Huang, {Tsi S.} and Lee, {S. S J} and Tu, {Hui Z.} and Huang, {Wen Kuei} and Chen, {Yao Shen} and Huang, {Chung K.} and Wann, {Shue R.} and Lin, {Hsi Hsun} and Liu, {Yung Ching}",
year = "2004",
month = "4",
doi = "10.1093/jac/dkh120",
language = "English",
volume = "53",
pages = "600--603",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide

AU - Huang, Tsi S.

AU - Lee, S. S J

AU - Tu, Hui Z.

AU - Huang, Wen Kuei

AU - Chen, Yao Shen

AU - Huang, Chung K.

AU - Wann, Shue R.

AU - Lin, Hsi Hsun

AU - Liu, Yung Ching

PY - 2004/4

Y1 - 2004/4

N2 - Objectives: Tentative standards for testing MICs for Mycobacterium tuberculosis include agar dilution and the BACTEC method. However, the conventional agar dilution method requires 3-5 weeks to complete; whereas BACTEC, although a rapid test, involves the use of radioisotopes. In contrast, the MGIT 960 system uses a fluorescence quenching based oxygen sensor that can be read automatically. This system is not only robust, safe and simple, but has been validated for susceptibility tests of first-line antituberculous agents. Methods: We evaluated 46 clinical strains of M. tuberculosis isolated from patients admitted to Kaohsiung Veterans General Hospital. Testing of MICs of ciprofloxacin and ethionamide was carried out by MGIT 960 and compared with the agar dilution method. Results: Good agreement was found between MGIT 960 and agar dilution. The greatest concordance between the agar dilution and MGIT assay at ±1 and ±2 dilution was 80.4% and 97.8% for ciprofloxacin, and 82.6% and 93.5% for ethionamide, respectively. Conclusion: MGIT 960 was found to be comparable to the current NCCLS standard method, agar dilution, and has the advantage of being rapid (obtaining results within 5-17 days, average 8.9 days) and easy to achieve standardization.

AB - Objectives: Tentative standards for testing MICs for Mycobacterium tuberculosis include agar dilution and the BACTEC method. However, the conventional agar dilution method requires 3-5 weeks to complete; whereas BACTEC, although a rapid test, involves the use of radioisotopes. In contrast, the MGIT 960 system uses a fluorescence quenching based oxygen sensor that can be read automatically. This system is not only robust, safe and simple, but has been validated for susceptibility tests of first-line antituberculous agents. Methods: We evaluated 46 clinical strains of M. tuberculosis isolated from patients admitted to Kaohsiung Veterans General Hospital. Testing of MICs of ciprofloxacin and ethionamide was carried out by MGIT 960 and compared with the agar dilution method. Results: Good agreement was found between MGIT 960 and agar dilution. The greatest concordance between the agar dilution and MGIT assay at ±1 and ±2 dilution was 80.4% and 97.8% for ciprofloxacin, and 82.6% and 93.5% for ethionamide, respectively. Conclusion: MGIT 960 was found to be comparable to the current NCCLS standard method, agar dilution, and has the advantage of being rapid (obtaining results within 5-17 days, average 8.9 days) and easy to achieve standardization.

KW - M. tuberculosis

KW - Minimum inhibitory concentration

KW - Susceptibility testing

UR - http://www.scopus.com/inward/record.url?scp=16544390121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16544390121&partnerID=8YFLogxK

U2 - 10.1093/jac/dkh120

DO - 10.1093/jac/dkh120

M3 - Article

VL - 53

SP - 600

EP - 603

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 4

ER -